evidence table
Saffron Anxiety Meta-Analysis Evidence Table
Structured evidence table for Saffron Anxiety Meta-Analysis, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Saffron Anxiety Meta-Analysis | Difficulties in accessing healthcare, their high costs, personal preferences, and the perceived safety of medicinal herbs have contributed to the increased usage of herbalism [,,]. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Anxiety Meta-Analysis | Given their popularity, it is crucial to have up‐to‐date risk and benefit assessments on these herbal products []. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Anxiety Meta-Analysis | Therefore, compiling a systematic review of human studies with the aim of summarizing the available evidence on the side effects ofnot only fills the gap in the literature but also seems essential for physicians, researchers, and health policymakers to use this widely used medicinal plant safely and rationally. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Anxiety Meta-Analysis | sativus 1 1 2 2 3 Saffron (L.) is a sophisticated spice with culinary and therapeutic importance []. | 1 | Hasheminasab Fatemeh Sadat (2026) | Adverse Events of Saffron ( Crocus sativus L.): Systematic Review of Current Evidence |
| Saffron Anxiety Meta-Analysis | This literature review synthesises evidence from randomised controlled trials, meta-analyses, safety data, dosing patterns, proposed mechanisms, and guideline positioning regarding saffron in depression, with a focus on adult major depressive disorder and related depressive symptomatology. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Anxiety Meta-Analysis | Across placebo-controlled trials in mild-to-moderate depression, saffron, most commonly administered at 30 mg per day for approximately six weeks, has been associated with clinically meaningful reductions in depressive symptom severity, typically measured using the Hamilton Depression Rating Scale (HAM-D). | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Anxiety Meta-Analysis | Meta-analytic evidence generally indicates superiority over placebo and similar efficacy to selective serotonin reuptake inhibitors (SSRIs), with an overall favourable short-term tolerability profile; however, confidence is constrained by small sample sizes, restricted settings, variable product standardisation (including stigma versus petal preparations), and risk of bias/publication bias. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
| Saffron Anxiety Meta-Analysis | Saffron ( Crocus sativus L.) has attracted increasing interest as a nutraceutical option for depressive disorders, particularly for patients who experience incomplete response or poor tolerability with conventional treatments. | 4 | Dimech L (2026) | The Role of Saffron in the Treatment of Depression: A Literature Review. |
Source documents